Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic
  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Eurofins Clinical Diagnostics Launches Lower Cost Highly Accurate COVID-19 PCR Test

Eurofins U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price per PCR test for clients. Pooling tests, historically used in blood banks, can now be used by the myriad of industries seeking a highly accurate and cost-effective means to conduct COVID-19 testing. Those industries include corporations, sports organizations, educational institutions, congregate care/nursing, and manufacturing.

Along with sentinel assays, pooled testing will be another integral tool in Eurofins’ comprehensive SARS-CoV-2 SAFER@WORK™ programme. The test will be offered through its network of U.S. laboratories, including Viracor Eurofins beginning mid-August. Pooling can be used to continuously and cost-effectively monitor prescreened, low-risk groups that show a low prevalence of COVID-19 infection. It can also be used as part of surveillance testing for positive individuals in quarantine. Weekly or bi-weekly pooling in combination with other Eurofins’ SARS-CoV-2 antibody, surface, wastewater, air and used mask assays, can help organisations reduce the risk of the current pandemic for significantly less than using regular PCR tests.

In pooled testing, Eurofins will pool five specimens and then test a single PCR assay while retaining the original, individual samples. Results are typically provided within 24-48 hours. If SARS-CoV-2 is detected in the pool, individual PCR tests will be performed to definitively identify the individual sample(s) that were positive. If there is no virus detected in the pool, no further testing is required.

Due to the strong sensitivity of the Eurofins’ RT-PCR assay, pooling represents a highly accurate method with very high sensitivity and excellent specificity.

Eurofins U.S. Clinical Diagnostics division submitted its pooling assay to the FDA for an Emergency Use Authorization on 24 July 2020. Eurofins started PCR pooling tests in Germany in early July 2020.

The Eurofins U.S. Clinical Diagnostics network began RT-PCR (real-time reverse-transcriptase polymerase chain reaction) testing for SARS-CoV-2 on March 13. Since then, Eurofins’ laboratories have rolled out highly sensitive and specific molecular assays to thousands of clients nationwide, including hospitals, physicians’ offices, nursing homes, governmental organizations and employers.

About Eurofins – the global leader in bio-analysis

With over 47,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts:

Annemarie Watson
ir@eurofins.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.